PLTR · Palantir Technologies Inc.
10-Q filed 2026-08-04 period 2026-06-30
93 Strong
confidence high · source filing on SEC.gov ↗
- Revenue grew by 93% YoY to $1.9 billion in Q2 2026, driven by 110% growth in the Commercial segment and 79% growth in the Government segment.
- Operating margin expanded significantly to 47% in Q2 2026 from 27% in Q2 2025, demonstrating substantial operating leverage.
- Cash and marketable securities reached $9.4 billion with zero debt, providing an exceptionally strong liquidity position.
vs. prior filing (10-Q filed 2026-05-05)
FHS 94 → 93 (-1) · Strong -> Strong
Profitability -3Balance sheet +3Cash generation -1Risk flags +0Mgmt signal -3
Filing Health Score pillars
Profitability 25%
95
Revenue grew 93% YoY in Q2 2026 to $1.9 billion, while operating margin expanded from 27% to 47% due to strong operating leverage (Results of Operations).
Balance sheet 20%
98
The balance sheet is exceptionally strong with $9.4 billion in cash and marketable securities, zero debt, and a current ratio of 7.2 (Condensed Consolidated Balance Sheets).
Cash generation 20%
96
Operating cash flow of $2.1 billion exceeded net income of $1.9 billion for the first six months of 2026, yielding an outstanding free cash flow margin of 58.7% on minimal capex (Condensed Consolidated Statements of Cash Flows).
Risk flags 20%
85
The company is clean of going-concern issues or restatements, but exhibits customer concentration with Customer I representing 27% of accounts receivable (Note 2, Concentrations of Credit Risk).
Mgmt signal 15%
92
Management signals strong momentum, particularly in the commercial segment which grew 110% YoY, driven by the rapid adoption of AI features and platforms (Comparison of the Three and Six Months Ended June 30, 2026 and 2025).
Key metrics (Six Months Ended June 30, 2026)
period: Six Months Ended June 30, 2026
total debt: $0
cash and equivalents: $2,030,047 thousand
shares outstanding: 2,402,897 thousand shares (Class A, B, and F combined as of June 30, 2026)
revenue: $3,568,047 thousand
net income: $1,942,364 thousand
operating cash flow: $2,115,332 thousand
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.